Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whole30 is a health and wellness company that manages the Whole30 program, a 30-day nutritional reset designed to help participants identify food sensitivities and improve their relationship with food. Founded in 2009, the company provides a structured elimination diet protocol that removes sugar, alcohol, grains, legumes, and dairy to address issues such as chronic inflammation, digestive problems, and low energy. The business operates through a multi-faceted model including digital resources, a series of New York Times best-selling books, and the 'Whole30 Approved' certification for food brands. Whole30 has built a massive global community and partners with numerous consumer packaged goods companies to provide compatible food options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whole30.